These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23849739)

  • 1. da Costa and colleagues' criticism of PEDro scores is not supported by the data.
    Costa LO; Maher CG; Moseley AM; Elkins MR; Shiwa SR; Herbert RD; Sherrington C
    J Clin Epidemiol; 2013 Oct; 66(10):1192-3. PubMed ID: 23849739
    [No Abstract]   [Full Text] [Related]  

  • 2. Not PEDro's bias: summary quality scores can be used in meta-analysis.
    Doi SA; Barendregt JJ
    J Clin Epidemiol; 2013 Aug; 66(8):940-1. PubMed ID: 23651766
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.
    Pisters PW; Lee JE; Vauthey JN; Evans DB
    Ann Surg; 2003 Apr; 237(4):594-5; author reply 595-6. PubMed ID: 12677158
    [No Abstract]   [Full Text] [Related]  

  • 4. PEDro's bias: summary quality scores should not be used in meta-analysis.
    da Costa BR; Hilfiker R; Egger M
    J Clin Epidemiol; 2013 Jan; 66(1):75-7. PubMed ID: 23177896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meta-analyses to reveal insufficient mega-trials].
    Graudal NA; Galløe AM
    Ugeskr Laeger; 1998 Jun; 160(24):3574. PubMed ID: 9641048
    [No Abstract]   [Full Text] [Related]  

  • 6. Value and limitation of meta-analysis.
    Verstraete M
    Pathophysiol Haemost Thromb; 2002; 32(5-6):278-81. PubMed ID: 13679657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment of meta-analyses on the basis of quality scores should be abandoned.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2006 Dec; 59(12):1249-56. PubMed ID: 17098567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can quality of clinical trials and meta-analyses be quantified?
    Ioannidis JP; Lau J
    Lancet; 1998 Aug; 352(9128):590-1. PubMed ID: 9746014
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding placebo effects in homeopathic clinical trials.
    Thompson T; Weiss M
    J Altern Complement Med; 2005 Oct; 11(5):784. PubMed ID: 16296906
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabias: a challenge for comparative effectiveness research.
    Goodman S; Dickersin K
    Ann Intern Med; 2011 Jul; 155(1):61-2. PubMed ID: 21727295
    [No Abstract]   [Full Text] [Related]  

  • 11. GRADE guidelines: 5. Rating the quality of evidence--publication bias.
    Guyatt GH; Oxman AD; Montori V; Vist G; Kunz R; Brozek J; Alonso-Coello P; Djulbegovic B; Atkins D; Falck-Ytter Y; Williams JW; Meerpohl J; Norris SL; Akl EA; Schünemann HJ
    J Clin Epidemiol; 2011 Dec; 64(12):1277-82. PubMed ID: 21802904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fables or foibles: inherent problems with RCTs.
    Rosner A
    J Manipulative Physiol Ther; 2003 Sep; 26(7):460-7. PubMed ID: 12975633
    [No Abstract]   [Full Text] [Related]  

  • 13. [Meta-analyses in psychopharmacotherapy: garbage in--garbage out?].
    Weinmann S
    Psychiatr Prax; 2009 Sep; 36(6):255-7. PubMed ID: 19707997
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcomes in randomized trials: Typology, relevance and importance for their standardization. Example of renoprotection].
    Sautenet B; Halimi JM; Caille A; Giraudeau B
    Presse Med; 2015 Nov; 44(11):1096-102. PubMed ID: 26454307
    [No Abstract]   [Full Text] [Related]  

  • 16. Cautionary tales in the interpretation of systematic reviews of therapy trials.
    Scott I; Greenberg P; Poole P; Campbell D
    Intern Med J; 2006 Sep; 36(9):587-99. PubMed ID: 16911551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. There was evidence of convergent and construct validity of Physiotherapy Evidence Database quality scale for physiotherapy trials.
    Macedo LG; Elkins MR; Maher CG; Moseley AM; Herbert RD; Sherrington C
    J Clin Epidemiol; 2010 Aug; 63(8):920-5. PubMed ID: 20171839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of homoeopathy trials.
    Seed P
    Lancet; 1998 Jan; 351(9099):365; author reply 367-8. PubMed ID: 9652637
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
    Moher D; Cook DJ; Jadad AR; Tugwell P; Moher M; Jones A; Pham B; Klassen TP
    Health Technol Assess; 1999; 3(12):i-iv, 1-98. PubMed ID: 10374081
    [No Abstract]   [Full Text] [Related]  

  • 20. The PEDro scale had acceptably high convergent validity, construct validity, and interrater reliability in evaluating methodological quality of pharmaceutical trials.
    Yamato TP; Maher C; Koes B; Moseley A
    J Clin Epidemiol; 2017 Jun; 86():176-181. PubMed ID: 28288916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.